References
- HartRGPearceLAAguilarMIMeta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillationAnn Intern Med20071461285786717577005
- LoewenPDahriKRisk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rulesAnn Hematol201190101191120021670974
- KirchhofPBenussiSKotechaD2016ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSEuropace201618111609167827567465
- JanuaryCTWannLSAlpertJS2014AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm SocietyCirculation2014130232071210424682348
- ChanKELazarusJMThadhaniRHakimRMWarfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillationJ Am Soc Nephrol200920102223223319713308
- ShahMAvgil TsadokMJackeviciusCAWarfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysisCirculation2014129111196120324452752
- ShenJIMontez-RathMELenihanCRTurakhiaMPChangTIWinkelmayerWCOutcomes after warfarin initiation in a cohort of hemodialysis patients with newly diagnosed atrial fibrillationAm J Kidney Dis201566467768826162653
- WakasugiMKazamaJJTokumotoAAssociation between warfarin use and incidence of ischemic stroke in Japanese hemodialysis patients with chronic sustained atrial fibrillation: a prospective cohort studyClin Exp Nephrol201418466266924113782
- WinkelmayerWCLiuJSetoguchiSChoudhryNKEffectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillationClin J Am Soc Nephrol20116112662266821959598
- OlesenJBLipGYKamperALStroke and bleeding in atrial fibrillation with chronic kidney diseaseN Engl J Med2012367762563522894575
- BrodskySVNadasdyTRovinBHWarfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rateKidney Int201180218118921389969
- BöhmMEzekowitzMDConnollySJChanges in renal function in patients with atrial fibrillation: an analysis from the RE-LY trialJ Am Coll Cardiol201565232481249326065986
- WizemannVTongLSatayathumSAtrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapyKidney Int201077121098110620054291
- AbbottKCTrespalaciosFCTaylorAJAgodoaLYAtrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortalityBMC Nephrol20034112546711
- BrodskySVSatoskarAChenJAcute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 casesAm J Kidney Dis20095461121112619577348
- HolbrookAMPereiraJALabirisRSystematic overview of warfarin and its drug and food interactionsArch Intern Med2005165101095110615911722
- WheelerDSGiuglianoRPRangaswamiJAnticoagulation-related nephropathyJ Thromb Haemost201614346146726670286
- ChatrouMLWinckersKHackengTMReutelingspergerCPSchurgersLJVascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonistsBlood Rev201226415516622520397
- SchurgersLJJoosenIALauferEMVitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotypePLoS One201278e4322922952653
- LimdiNABeasleyTMBairdMFKidney function influences warfarin responsiveness and hemorrhagic complicationsJ Am Soc Nephrol200920491292119225037
- LeveyASStevensLASchmidCHA new equation to estimate glomerular filtration rateAnn Intern Med2009150960461219414839
- JamesPAOparilSCarterBL2014Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)JAMA2014311550752024352797
- ERA/EDTA Registry(ERA/EDTA) Registry Annual Report 2009Amsterdam, the NetherlandsAcademic Medical Center, Department of Medical Informatics2011
- van den BeukelTOde GoeijMCDekkerFWSiegertCEHalbesmaNPREPARE Study GroupDifferences in progression to ESRD between black and white patients receiving predialysis care in a universal health care systemClin J Am Soc Nephrol2013891540154723846464
- JagerKJvan DijkPCZoccaliCDekkerFWThe analysis of survival data: the Kaplan-Meier methodKidney Int200874556056518596735
- HerzogCAAsingerRWBergerAKCardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)Kidney Int201180657258621750584
- Van Der MeerschHDe BacquerDDe VrieseASVitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysisAm Heart J2017184374627892885
- SolimanEZPrineasRJGoASChronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC)Am Heart J201015961102110720569726
- VoormolenNNoordzijMGrootendorstDCHigh plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patientsNephrol Dial Transplant200722102909291617517792
- de GoeijMCMeulemanYvan DijkSHaemoglobin levels and health-related quality of life in young and elderly patients on specialized predialysis careNephrol Dial Transplant20142713911398
- VoormolenNNoordzijMGrootendorstDCHigh plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patientsNephrol Dial Transplant200722102909291617517792